Underreporting of major obstetric haemorrhage in the Netherlands.
نویسندگان
چکیده
Major obstetric haemorrhage (MOH) is the main cause of severe maternal morbidity, incidence being estimated at 4.5 per 1000 deliveries. Cases are not routinely registered in the Netherlands. The objective of this study is to quantify the degree of underreporting of MOH in a large nationwide survey of severe acute maternal morbidity in the Netherlands (LEMMoN) and to estimate the true incidence of MOH in the Netherlands. Retrospective cross-match of the LEMMoN-database with the databases of local blood transfusion laboratories in 65 of 98 hospitals in the Netherlands during a 20-month period, using the capture-recapture method was used. From 16 of 65 centres, the reported transfusion data could not be confirmed by a local obstetrician for logistical reasons. These centres were excluded leaving 49 hospitals available for final analysis. In both databases together, 1018 unique cases of MOH were identified. Underreporting to LEMMoN was 35%. Hence, the true incidence of MOH in the Netherlands is at least 6.1 instead of 4.5 per 1000 deliveries. The estimated underreporting of MOH of 35% is considerable. Underreporting is inherent to large observational multicentre studies and should be anticipated and quantified to facilitate fair comparison of epidemiologic data.
منابع مشابه
Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use
Major obstetric haemorrhage remains a significant cause of maternal morbidity and mortality. Previous case reports suggest the potential benefit of recombinant activated factor VII (rFVIIa: NovoSeven(R)) as a haemostatic agent. We performed a retrospective review of the use of rVIIa in major obstetric haemorrhage in the Northern Region between July 2004 and February 2007. Fifteen women received...
متن کاملStrategies to manage major obstetric haemorrhage.
PURPOSE OF REVIEW Haemorrhage remains a cause of significant maternal morbidity and mortality. This review summarizes the prevention, management and treatment of obstetric haemorrhage and highlights recent advances and developments. RECENT FINDINGS Postpartum haemorrhage is the most common cause of major obstetric haemorrhage and is usually due to uterine atony. Pharmacological treatment has ...
متن کاملAnesthesia and the Risk of Stillbirths
methods _or wn, and preventing our materknow the standard nal ledge of deaths such are hazards well knolity inceais ses, continue but unfortud.ay, nately obstetric morta although is expected to be rare. the most common causes of obstetric deaths are: 1- Haemorrhage 2- Infection 3- Anaesthesia 4-Toxaemia 5-The supine hypotensive syndrome 6- Aspiration of Stomach contents in to the...
متن کاملThe Efficacy of Fibrinogen Concentrate Compared to Cryoprecipitate in Major Obstetric Haemorrhage – an Observational Study. Authors
Background Fibrinogen replacement is critical in major obstetric haemorrhage (MOH).Purified, pasteurized fibrinogen concentrate appears to have benefitover cryoprecipitate in ease of administration and safety but is unlicensed in pregnancy. In July 2009 the Irish Blood Transfusion Service replaced cryoprecipitate with fibrinogen.
متن کاملSevere Adverse Maternal Outcomes among Women in Midwife-Led versus Obstetrician-Led Care at the Onset of Labour in the Netherlands: A Nationwide Cohort Study
OBJECTIVE To test the hypothesis that it is possible to select a group of low risk women who can start labour in midwife-led care without having increased rates of severe adverse maternal outcomes compared to women who start labour in secondary care. DESIGN AND METHODS We conducted a nationwide cohort study in the Netherlands, using data from 223 739 women with a singleton pregnancy between 3...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Transfusion medicine
دوره 20 2 شماره
صفحات -
تاریخ انتشار 2010